| 04/03/2026 3:15 PM | Entera Bio (1638097) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/27/2026 3:20 PM | Entera Bio (1638097) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/11/2026 7:30 AM | Entera Bio (1638097) Issuer Germano Geno J (1424383) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/09/2026 7:30 AM | Ellis Sean (1904752) Reporting Entera Bio (1638097) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 8:00 AM | Entera Bio (1638097) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/17/2026 7:30 AM | Entera Bio (1638097) Issuer Rubin Steven D (1381874) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 7:42 AM | Ellis Sean (1904752) Reporting Entera Bio (1638097) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 7:44 AM | Entera Bio (1638097) Issuer Rubin Steven D (1381874) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 7:45 AM | Entera Bio (1638097) Issuer Germano Geno J (1424383) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 7:47 AM | Entera Bio (1638097) Issuer Taitel Haya (1979599) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/09/2026 7:46 AM | Entera Bio (1638097) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for ENTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Entera Bio and its competitors with MarketBeat's FREE daily newsletter.
|
| 02/09/2026 7:50 AM | Entera Bio (1638097) Issuer Germano Geno J (1424383) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 02/04/2026 7:00 AM | Entera Bio (1638097) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/02/2026 3:23 PM | Entera Bio (1638097) Issuer Malca Yonatan (1904759) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/02/2026 3:25 PM | Ellis Sean (1904752) Reporting Entera Bio (1638097) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/02/2026 3:27 PM | Entera Bio (1638097) Issuer OSTROV GERALD M (1534739) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/02/2026 3:17 PM | Entera Bio (1638097) Issuer Taitel Haya (1979599) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/02/2026 3:21 PM | Entera Bio (1638097) Issuer LIEBERMAN GERALD M (1234346) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/30/2025 5:01 AM | Entera Bio (1638097) Issuer Toledano Miranda Jayne (1686530) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/14/2025 3:06 PM | Entera Bio (1638097) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/14/2025 3:06 PM | Entera Bio (1638097) Subject Point72 Asset Management, L.P. (1603466) Filed by | Form SCHEDULE 13G/A | |
| 07/28/2025 6:35 AM | Entera Bio (1638097) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/18/2025 3:34 PM | Entera Bio (1638097) Issuer Yaacov-Garbeli Dana (1909822) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/18/2025 3:35 PM | Burshtein Gregory (2026002) Reporting Entera Bio (1638097) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/18/2025 3:37 PM | Entera Bio (1638097) Issuer Toledano Miranda Jayne (1686530) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/18/2025 3:29 PM | Entera Bio (1638097) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/08/2025 11:15 PM | Entera Bio (1638097) Filer | Form EFFECT | |
| 06/05/2025 3:25 PM | Entera Bio (1638097) Filer | Form ARS | |